Santaris Pharma
AcquiredCopenhagen, Denmark · Founded 2003
- Headquarters
- Copenhagen
- Founded
- 2003
- Business Model
- B2B
- Website
- santaris.com
- Last Round
- Venture RoundJun 2012
- Rounds
- 2
- Acquired by
- RocheAug 2014 · $250.0M
Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.
About
Santaris Pharma A/S was a Copenhagen, Denmark-based biopharmaceutical company founded in 2003 through the merger of Cureon and Pantheco, with a second research site opened in San Diego in 2009. The company developed RNA-targeted medicines using its proprietary Locked Nucleic Acid (LNA) Drug Platform, advancing candidates for cancer, hepatitis C, and cardiometabolic disease, and partnering with Pfizer, GlaxoSmithKline, Shire, Enzon, and Bristol-Myers Squibb. In August 2014, Roche acquired Santaris for up to $450 million, renaming the Copenhagen site the Roche Innovation Center Copenhagen, which was fully closed in 2023 when Roche consolidated RNA research in Basel.
Summary
Santaris Pharma is a Biotech company based in Copenhagen, Denmark, founded in 2003. Its most recent funding was a Venture Round in Jun 2012. Investors include Forbion Capital Partners, Roche and Gilde Healthcare.
Funding & Exit History
Aug 2014
Sign up to see all 3 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/santaris-pharma"><img src="https://indexed.vc/api/badge/company/santaris-pharma" alt="Santaris Pharma on Indexed.vc" width="260" height="76" /></a>